What blood work is recommended for a patient suspected of having Polycystic Ovary Syndrome (PCOS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Evaluation for Suspected PCOS

For a patient with suspected PCOS, order total or free testosterone (preferably by LC-MS/MS), TSH, prolactin, a 2-hour 75g oral glucose tolerance test, and a fasting lipid panel as your core initial workup. 1, 2, 3

First-Line Essential Tests

Androgen Assessment

  • Measure total testosterone or free testosterone using liquid chromatography-tandem mass spectrometry (LC-MS/MS) as your primary androgen marker, which shows pooled sensitivity of 74% and specificity of 86% for PCOS diagnosis 1
  • LC-MS/MS is mandatory over direct immunoassays because it demonstrates superior specificity (92% vs 78%), reducing false positives 1, 2
  • Free testosterone shows even better sensitivity (89%) with specificity of 83%, making it an excellent first-line option 1
  • Important caveat: Total testosterone is abnormal in only 70% of confirmed PCOS cases, meaning 30% will have normal levels despite having the condition 1

Exclusion of Other Endocrine Disorders

  • Measure TSH to rule out thyroid disease as an alternative cause of menstrual irregularity 1, 2, 3
  • Measure prolactin using morning resting serum levels to exclude hyperprolactinemia, with levels >20 μg/L considered abnormal 1, 3
  • If prolactin is elevated, confirm with 2-3 samples at 20-60 minute intervals via indwelling cannula to exclude stress-related spurious elevation 1
  • Measure 17-hydroxyprogesterone to exclude nonclassic congenital adrenal hyperplasia 2, 3

Mandatory Metabolic Screening

  • Order a 2-hour oral glucose tolerance test with 75g glucose load to screen for type 2 diabetes and glucose intolerance, regardless of BMI 1, 2, 3
  • Order fasting lipid panel including total cholesterol, LDL, HDL, and triglycerides to assess dyslipidemia driven by insulin resistance 1, 3
  • Target values: LDL <100 mg/dL, HDL >35 mg/dL, triglycerides <150 mg/dL 1
  • All women with PCOS require metabolic screening regardless of body weight, as insulin resistance occurs independently of BMI 2

Second-Line Tests (If Clinical Suspicion Remains High Despite Normal First-Line Tests)

Additional Androgen Markers

  • Measure androstenedione (A4) if total testosterone and free testosterone are normal but clinical suspicion persists, with sensitivity of 75% and specificity of 71% 1
  • Measure DHEAS as an adjunctive test, with sensitivity of 75% and specificity of 67% 1
  • These have poorer specificity than testosterone and should only be used as supplementary tests, not primary markers 1

Gonadotropin Assessment

  • Measure LH and FSH between days 3-6 of menstrual cycle, calculating based on an average of three estimations taken 20 minutes apart 1
  • An LH/FSH ratio >2 suggests PCOS, but this is abnormal in only 35-44% of women with PCOS, making it a poor standalone diagnostic marker 1
  • Critical pitfall: Do not rely on LH/FSH ratio as a primary diagnostic criterion due to its low sensitivity 4

Ovulation Assessment

  • Measure progesterone during mid-luteal phase to confirm anovulation, with levels <6 nmol/L indicating anovulation 1

Physical Assessment Parameters

Anthropometric Measurements

  • Calculate BMI to assess obesity, with BMI >25 considered obese 1, 2, 3
  • Measure waist-hip ratio to identify central obesity, with WHR >0.9 indicating truncal obesity and increased metabolic risk 1, 3
  • Central obesity exacerbates metabolic, reproductive, and psychological features of PCOS 1

Clinical Signs of Insulin Resistance

  • Examine for acanthosis nigricans on neck, axillae, under breasts, and vulva, which indicates underlying insulin resistance 2, 3

Tests to Exclude Serious Pathology

When to Screen for Cushing's Syndrome

  • Order dexamethasone suppression test if patient presents with buffalo hump, moon facies, hypertension, abdominal striae, central fat distribution, easy bruising, or proximal myopathies 1, 2

When to Consider Androgen-Secreting Tumors

  • Suspect if rapid onset of symptoms, severe hirsutism, or very high testosterone levels (>4.8 nmol/L) 1, 5

Special Considerations

Anti-Müllerian Hormone (AMH)

  • Do not use AMH levels as an alternative for detecting polycystic ovarian morphology or as a single test for PCOS diagnosis 1, 2
  • While AMH ≥35 pmol/L shows 92% sensitivity and 97% specificity, it lacks assay standardization and validated cut-offs 1, 2

Ultrasound Considerations

  • If the patient has both irregular menstrual cycles AND clinical/biochemical hyperandrogenism, ultrasound is not necessary for diagnosis 1, 2
  • Ultrasound should not be used for PCOS diagnosis in adolescents with gynecological age <8 years post-menarche due to physiologically normal multifollicular ovaries 1, 2

Critical Diagnostic Algorithm

  1. Start with testosterone (total or free by LC-MS/MS), TSH, prolactin, 2-hour OGTT, and fasting lipids 1, 2, 3
  2. If testosterone normal but clinical suspicion high, add androstenedione and DHEAS 1
  3. Measure 17-hydroxyprogesterone to exclude CAH 2, 3
  4. Calculate BMI and waist-hip ratio, examine for acanthosis nigricans 2, 3
  5. Remember: A woman can be diagnosed with PCOS based solely on clinical hyperandrogenism plus irregular menstrual cycles, without any abnormal laboratory values, per Rotterdam criteria 1

References

Guideline

Laboratory Evaluations for Suspected Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosis of Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

PCOS Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Which hormone tests for the diagnosis of polycystic ovary syndrome?

British journal of obstetrics and gynaecology, 1992

Research

Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients.

Human reproduction (Oxford, England), 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.